Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin pharmacokinetics during obstetric or fetal surgery
2023-503653-35-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clindamycin in twin-twin transfusion syndrome (TTTS), intrauterine growth restriction (IUGR), congenital diaphragmatic hernia (CDH) and 3 more, sponsored by UZ Leuven. Started Aug 2023; status: completed.
02
Drugs
clindamycin
03
Conditions
twin-twin transfusion syndrome (TTTS)intrauterine growth restriction (IUGR)congenital diaphragmatic hernia (CDH)myelomeningocele (MMC)pregnancy
Beyond the preview
Go deeper on 2023-503653-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503653-35-00.